Published in J Biol Chem on September 15, 1985
A continuous fluorescence displacement assay for the measurement of phospholipase A2 and other lipases that release long-chain fatty acids. Biochem J (1990) 1.06
Crystal structure of phospholipase A2 from Indian cobra reveals a trimeric association. Proc Natl Acad Sci U S A (1993) 0.96
Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties. J Inflamm (Lond) (2008) 0.91
Comparison of the catalytic properties of phospholipase A2 from pancreas and venom using a continuous fluorescence displacement assay. Biochem J (1991) 0.85
Phospholipase A2 action on planar lipid bilayers generates a small, transitory current that is voltage independent. Biophys J (1997) 0.80
Surface dilution kinetics of phospholipase A(2) catalyzed lipid-bilayer hydrolysis. J Phys Chem B (2014) 0.77
LysoPC acyltransferase/PC transacylase activities in plant plasma membrane and plasma membrane-associated endoplasmic reticulum. BMC Plant Biol (2007) 0.77
Liberating Chiral Lipid Mediators, Inflammatory Enzymes, and LIPID MAPS from Biological Grease. J Biol Chem (2016) 0.75
Inactivation of secretory phospholipase A2 by ionizing radiation. Biophys J (1995) 0.75
Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med (1998) 5.78
In vitro selection and evolution of functional proteins by using ribosome display. Proc Natl Acad Sci U S A (1997) 4.71
The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta (2000) 4.62
In vitro generated antibodies specific for telomeric guanine-quadruplex DNA react with Stylonychia lemnae macronuclei. Proc Natl Acad Sci U S A (2001) 3.97
Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science (1988) 3.38
Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci U S A (1999) 2.85
Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest (1999) 2.81
Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids. J Biol Chem (1987) 2.75
Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J Mol Biol (2000) 2.73
Stability engineering of antibody single-chain Fv fragments. J Mol Biol (2001) 2.58
Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J Immunol Methods (1997) 2.44
Lipid signaling enzymes and surface dilution kinetics. J Biol Chem (1995) 2.41
Inhibition of macrophage Ca(2+)-independent phospholipase A2 by bromoenol lactone and trifluoromethyl ketones. J Biol Chem (1995) 2.23
An in vivo library-versus-library selection of optimized protein-protein interactions. Nat Biotechnol (1999) 2.09
Solubilization of phospholipids by detergents. Structural and kinetic aspects. Biochim Biophys Acta (1983) 2.05
Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat Biotechnol (1999) 2.03
Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol (1999) 1.98
Competition BIAcore for measuring true affinities: large differences from values determined from binding kinetics. Anal Biochem (1996) 1.94
Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis. Nucleic Acids Res (1994) 1.85
Antigen binding forces of individually addressed single-chain Fv antibody molecules. Proc Natl Acad Sci U S A (1998) 1.85
Scavenger receptors, oxidized LDL, and atherosclerosis. Ann N Y Acad Sci (2001) 1.82
The geometry of the transition state in the hydrolysis of phosphate esters. J Am Chem Soc (1966) 1.81
BIACORE analysis of histidine-tagged proteins using a chelating NTA sensor chip. Anal Biochem (1997) 1.79
Sequence statistics reliably predict stabilizing mutations in a protein domain. J Mol Biol (1994) 1.77
The functional expression of antibody Fv fragments in Escherichia coli: improved vectors and a generally applicable purification technique. Biotechnology (N Y) (1991) 1.74
Novel fold and capsid-binding properties of the lambda-phage display platform protein gpD. Nat Struct Biol (2000) 1.71
Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. Proc Natl Acad Sci U S A (1998) 1.69
Increasing the secretory capacity of Saccharomyces cerevisiae for production of single-chain antibody fragments. Nat Biotechnol (1998) 1.68
Intracellular sites of lipid synthesis and the biogenesis of mitochondria. J Lipid Res (1972) 1.66
Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display. Nat Biotechnol (2000) 1.65
Irreversible inhibition of Ca(2+)-independent phospholipase A2 by methyl arachidonyl fluorophosphonate. Biochim Biophys Acta (1996) 1.62
Inhibition of calcium-independent phospholipase A2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages. Proc Natl Acad Sci U S A (1995) 1.61
A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry (1990) 1.60
Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. Proc Natl Acad Sci U S A (1999) 1.58
Kinetic analysis of phospholipase A2 activity toward mixed micelles and its implications for the study of lipolytic enzymes. J Biol Chem (1975) 1.55
The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J Biol Chem (2000) 1.54
Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages. J Biol Chem (1996) 1.54
Calcium-independent phospholipase A(2): structure and function. Biochim Biophys Acta (2000) 1.53
Acyl and phosphoryl migration in lysophospholipids: importance in phospholipid synthesis and phospholipase specificity. Biochemistry (1982) 1.53
Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool. J Mol Biol (2001) 1.53
Ca(2+)-independent cytosolic phospholipase A2 from macrophage-like P388D1 cells. Isolation and characterization. J Biol Chem (1994) 1.52
The mechanism of action of ribonuclease. Proc Natl Acad Sci U S A (1969) 1.51
The Escherichia coli heat shock proteins GroEL and GroES modulate the folding of the beta-lactamase precursor. EMBO J (1990) 1.50
Destabilization of the complete protein secondary structure on binding to the chaperone GroEL. Nature (1994) 1.49
Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli. Biochemistry (1992) 1.46
Protein folding in the periplasm of Escherichia coli. Mol Microbiol (1994) 1.46
Selection for improved protein stability by phage display. J Mol Biol (1999) 1.46
Chemical modification of the histidine residue in phospholipase A2 (Naja naja naja). A case of half-site reactivity. J Biol Chem (1977) 1.44
An improved affinity tag based on the FLAG peptide for the detection and purification of recombinant antibody fragments. Biotechniques (1994) 1.43
Antigen recognition by conformational selection. FEBS Lett (1999) 1.42
Evolutionary relationships and implications for the regulation of phospholipase A2 from snake venom to human secreted forms. J Mol Evol (1990) 1.40
In vitro display technologies: novel developments and applications. Curr Opin Biotechnol (2001) 1.40
Antisense inhibition of group VI Ca2+-independent phospholipase A2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages. J Biol Chem (1997) 1.37
The precursor of beta-lactamase: purification, properties and folding kinetics. EMBO J (1989) 1.37
Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment. Protein Eng (1997) 1.37
Interfacial properties and critical micelle concentration of lysophospholipids. Biochemistry (1989) 1.36
Bromoenol lactone inhibits magnesium-dependent phosphatidate phosphohydrolase and blocks triacylglycerol biosynthesis in mouse P388D1 macrophages. J Biol Chem (1996) 1.35
Function and inhibition of intracellular calcium-independent phospholipase A2. J Biol Chem (1997) 1.34
High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. Cancer Res (1999) 1.32
Engineered turns of a recombinant antibody improve its in vivo folding. Protein Eng (1995) 1.31
Identity between the Ca2+-independent phospholipase A2 enzymes from P388D1 macrophages and Chinese hamster ovary cells. J Biol Chem (1997) 1.31
Circular beta-lactamase: stability enhancement by cyclizing the backbone. FEBS Lett (1999) 1.30
Bacterial lipopolysaccharide priming of P388D1 macrophage-like cells for enhanced arachidonic acid metabolism. Platelet-activating factor receptor activation and regulation of phospholipase A2. J Biol Chem (1990) 1.30
Crystal structure of the dimeric C-terminal domain of TonB reveals a novel fold. J Biol Chem (2001) 1.30
Tailoring in vitro evolution for protein affinity or stability. Proc Natl Acad Sci U S A (2001) 1.26
Group IV cytosolic phospholipase A2 binds with high affinity and specificity to phosphatidylinositol 4,5-bisphosphate resulting in dramatic increases in activity. J Biol Chem (1998) 1.25
Tetravalent miniantibodies with high avidity assembling in Escherichia coli. J Mol Biol (1995) 1.24
Filamentous phage infection: crystal structure of g3p in complex with its coreceptor, the C-terminal domain of TolA. Structure (1999) 1.22
Recent advances in producing and selecting functional proteins by using cell-free translation. Curr Opin Biotechnol (1998) 1.21
Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment. Biochemistry (1998) 1.20
Analysis of human synovial fluid phospholipase A2 on short chain phosphatidylcholine-mixed micelles: development of a spectrophotometric assay suitable for a microtiterplate reader. Anal Biochem (1992) 1.20
Phospholipase A2 contamination of cobra venom factor preparations. Biologic role in complement-dependent in vivo reactions and inactivation with p-bromophenacyl bromide. Am J Pathol (1978) 1.19
Kinetic dependence of phospholipase A 2 activity on the detergent Triton X-100. J Lipid Res (1973) 1.19
Effects of overexpressing folding modulators on the in vivo folding of heterologous proteins in Escherichia coli. Curr Opin Biotechnol (1995) 1.18
Cleavage of procaryotically expressed human immunodeficiency virus fusion proteins by factor Xa and application in western blot (immunoblot) assays. J Clin Microbiol (1989) 1.17
Antibody scFv fragments without disulfide bonds made by molecular evolution. J Mol Biol (1998) 1.17
Identification of essential residues for the catalytic function of 85-kDa cytosolic phospholipase A2. Probing the role of histidine, aspartic acid, cysteine, and arginine. J Biol Chem (1996) 1.16
Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF. Br J Pharmacol (2010) 1.16
An Escherichia coli protein consisting of a domain homologous to FK506-binding proteins (FKBP) and a new metal binding motif. J Biol Chem (1994) 1.16
The periplasmic Escherichia coli peptidylprolyl cis,trans-isomerase FkpA. II. Isomerase-independent chaperone activity in vitro. J Biol Chem (2000) 1.16
Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. Anal Biochem (1999) 1.15
Enzymatic synthesis and decarboxylation of phosphatidylserine in Tetrahymena pyriformis. J Lipid Res (1970) 1.15
Metal ion and salt effects on the phospholipase A2, lysophospholipase, and transacylase activities of human cytosolic phospholipase A2. Biochim Biophys Acta (1993) 1.14
Improving in vivo folding and stability of a single-chain Fv antibody fragment by loop grafting. Protein Eng (1997) 1.14
The Escherichia coli SlyD is a metal ion-regulated peptidyl-prolyl cis/trans-isomerase. J Biol Chem (1997) 1.14
Model and simulation of multivalent binding to fixed ligands. Anal Biochem (1998) 1.13
The consequences of stepwise deletions from the signal-processing site of beta-lactamase. J Biol Chem (1987) 1.13
Novel group V phospholipase A2 involved in arachidonic acid mobilization in murine P388D1 macrophages. J Biol Chem (1996) 1.13
Atomic force microscopy detects changes in the interaction forces between GroEL and substrate proteins. Biophys J (1998) 1.13
Specific detection of his-tagged proteins with recombinant anti-His tag scFv-phosphatase or scFv-phage fusions. Biotechniques (1997) 1.12
Selection for a periplasmic factor improving phage display and functional periplasmic expression. Nat Biotechnol (1998) 1.12
Regional distribution, ontogeny, purification, and characterization of the Ca2+-independent phospholipase A2 from rat brain. J Neurochem (1999) 1.12
Different equilibrium stability behavior of ScFv fragments: identification, classification, and improvement by protein engineering. Biochemistry (1999) 1.11
Selecting proteins with improved stability by a phage-based method. Nat Biotechnol (1998) 1.10
Functional antibody production using cell-free translation: effects of protein disulfide isomerase and chaperones. Nat Biotechnol (1997) 1.10
A heterodimeric coiled-coil peptide pair selected in vivo from a designed library-versus-library ensemble. J Mol Biol (2000) 1.10
An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly. FEBS Lett (1998) 1.09
Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability. Biochemistry (1998) 1.09
Forces and energetics of hapten-antibody dissociation: a biased molecular dynamics simulation study. J Mol Biol (2001) 1.09